Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Decreased appetite
ADR ID BADD_A05900
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.09      Feelings and sensations NEC
08.01.09.028      Decreased appetite
14      Metabolism and nutrition disorders
14.03      Appetite and general nutritional disorders
14.03.01      Appetite disorders
14.03.01.005      Decreased appetite
Description The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA. [MeSH]
MedDRA Code 10061428
MeSH ID D000855
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Anorexia | Anorexic | Appetite absent | Appetite decreased NOS | Appetite impaired | Appetite lost | Appetite suppressed | Appetite suppression | Anorectic | Inappetence | Decreased appetite | Anorexia post chemotherapy | Hyporexia | Anorexias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02305Trospium--
BADD_D02307Trovafloxacin--
BADD_D02308Trovafloxacin mesylate--
BADD_D02319Urofollitropin--
BADD_D02321Ursodiol--
BADD_D02324Valacyclovir hydrochloride--
BADD_D02325Valdecoxib--
BADD_D02326Valganciclovir--
BADD_D02327Valganciclovir hydrochloride--
BADD_D02328Valproate sodium--
BADD_D02329Valproic acid--
BADD_D02331Valsartan--
BADD_D02334Vandetanib0.000437%
BADD_D02337Varenicline--
BADD_D02338Varenicline tartrate--
BADD_D02342Vedolizumab--
BADD_D02344Vemurafenib0.010891%
BADD_D02346Venlafaxine--
BADD_D02347Venlafaxine hydrochloride--
BADD_D02353Vesicare--
BADD_D02355Vigabatrin--
BADD_D02356Vilazodone hydrochloride--
BADD_D02358Vinblastine--
BADD_D02359Vinblastine sulfate--
BADD_D02360Vincristine0.000224%
BADD_D02361Vincristine sulfate--
BADD_D02362Vinflunine--
BADD_D02363Vinorelbine--
BADD_D02364Vinorelbine tartrate--
BADD_D02365Vismodegib0.015480%
The 34th Page    First    Pre   34 35 36 37    Next   Last    Total 37 Pages